{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:12:08Z","timestamp":1790507528179,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T09:18:51Z","timestamp":1502356731000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants"],"prefix":"10.1016","volume":"109","author":[{"given":"Mette","family":"Klitgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Jonas","family":"Sassene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Selen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"M\u00fcllertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5992-9688","authenticated-orcid":false,"given":"Ragna","family":"Berthelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.08.003_bb0005","series-title":"Bioanalytical Method Validation","author":"Administration USDoHaHSFaD","year":"2001"},{"key":"10.1016\/j.ejps.2017.08.003_bb0010","series-title":"General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products. Guidance for Industry. Draft guidance","author":"Administration USDoHaHSFaD","year":"2014"},{"key":"10.1016\/j.ejps.2017.08.003_bb0015","series-title":"Pediatric Study Plans: Content of and Process for Submitting Initial Pediatric Study Plans and Amended Initial Study Plans. Guidance for Industry. Draft Guidance. Draft Guidance","first-page":"2016","author":"Administration USDoHaHSFaD","year":"2016"},{"issue":"3","key":"10.1016\/j.ejps.2017.08.003_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejps.2017.08.003_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1203\/00006450-199609000-00011","article-title":"Effect of human milk or formula on gastric function and fat digestion in the premature infant","volume":"40","author":"Armand","year":"1996","journal-title":"Pediatr. Res."},{"issue":"6","key":"10.1016\/j.ejps.2017.08.003_bb0030","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00615967","article-title":"Reduced bioavailability and effect of furosemide given with food","volume":"29","author":"Beermann","year":"1986","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.08.003_bb0035","series-title":"Evaluating Oral Drug Delivery Systems: Digestion models Analytical Techniques in the Pharmaceutical Sciences","first-page":"773","article-title":"et al.","author":"Berthelsen","year":"2016"},{"issue":"4","key":"10.1016\/j.ejps.2017.08.003_bb0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000244419","article-title":"Bile acid concentrations in serum and duodenal aspirates of healthy preterm infants: effects of gestational and postnatal age","volume":"71","author":"Boehm","year":"1997","journal-title":"Biol. Neonate"},{"issue":"11","key":"10.1016\/j.ejps.2017.08.003_bb0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/10408398.2011.640757","article-title":"Specificity of infant digestive conditions: some clues for developing relevant in vitro models","volume":"54","author":"Bourlieu","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"8","key":"10.1016\/j.ejps.2017.08.003_bb0050","article-title":"Furosemide: a review of its use in infants and children","volume":"15","author":"Buck","year":"2009","journal-title":"Pediatr. Pharmacol."},{"key":"10.1016\/j.ejps.2017.08.003_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biochi.2015.11.016","article-title":"Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs","volume":"125","author":"Carriere","year":"2016","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.ejps.2017.08.003_bb0060","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0016-5085(93)90908-U","article-title":"Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans","volume":"105","author":"Carriere","year":"1993","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ejps.2017.08.003_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejps.2017.08.003_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0009-8981(59)90030-0","article-title":"On the bile acids in duodenal contents of infants and children bile acids and steroids 72","volume":"4","author":"Encrantz","year":"1959","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ejps.2017.08.003_bb0075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1542\/peds.62.5.811","article-title":"The use of furosemide in the treatment of edema in infants and children","volume":"62","author":"Engle","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2017.08.003_bb0080","article-title":"EC Regulation No 1901\/2006 of the European Parliament and of the council of 12 December 2006 on medicinal products for paediatric use and amending regulation (EEC) No 1768\/92, directive 2001\/20\/EC, directive 2001\/83\/EC and regulation (EC) No 726\/2004","author":"European Medicines Agency","year":"2006","journal-title":"Off. J. Eur. Union"},{"key":"10.1016\/j.ejps.2017.08.003_bb0085","series-title":"The European Paediatric Initiative: History of the Paediatric Regulation. Doc Ref: EMEA\/17967\/04 Rev 1","author":"European Medicines Agency","year":"2007"},{"key":"10.1016\/j.ejps.2017.08.003_bb0090","author":"European Medicines Agency"},{"issue":"8","key":"10.1016\/j.ejps.2017.08.003_bb2015","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s11095-009-9906-2","article-title":"In vitro gastrointestinal lipolysis of four formulations of piroxicam ans cannarizine with the self emulsifying excipients Labrosol and Gelucire 44\/14","volume":"26","author":"Fernandez","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.08.003_bb0095","author":"Frusol\u00ae"},{"key":"10.1016\/j.ejps.2017.08.003_bb0100","author":"Furix\u00ae"},{"issue":"6","key":"10.1016\/j.ejps.2017.08.003_bb0105","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jps.22030","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2017.08.003_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijpharm.2013.07.053","article-title":"In vitro gastrointestinal model (TIM) with predictive power, even for infants and children?","volume":"457","author":"Havenaar","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.08.003_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejps.2015.05.023","article-title":"Gastrointestinal behavior of nano- and microsized fenofibrate: in vivo evaluation in man and in vitro simulation by assessment of the permeation potential","volume":"77","author":"Hens","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2017.08.003_bb0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1542\/peds.72.5.677","article-title":"Feeding the low-birth-weight infant. III. Diet influences bile acid metabolism","volume":"72","author":"Jarvenpaa","year":"1983","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2017.08.003_bb0125","article-title":"In vitro model simulating gastro-intestinal digestion in the pediatric population (neonates and young infants)","author":"Kamstrup","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2017.08.003_bb0130","article-title":"Diuretics for transient tachypnoea of the newborn","volume":"11","author":"Kassab","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejps.2017.08.003_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/adc.37.194.387","article-title":"Some aspects of gastric function in the newborn","volume":"37","author":"Mason","year":"1962","journal-title":"Arch. Dis. Child."},{"issue":"10","key":"10.1016\/j.ejps.2017.08.003_bb0140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1517\/17425255.2012.698261","article-title":"Ontogeny of oral drug absorption processes in children","volume":"8","author":"Mooij","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2017.08.003_bb0145","author":"Nestl\u00e9"},{"issue":"5","key":"10.1016\/j.ejps.2017.08.003_bb0150","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/jphp.12365","article-title":"Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach","volume":"67","author":"Otsuka","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2017.08.003_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ejps.2017.08.003_bb0160","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1208\/s12248-014-9672-x","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels","volume":"16","author":"Sassene","year":"2014","journal-title":"AAPS J."},{"issue":"9","key":"10.1016\/j.ejps.2017.08.003_bb0165","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1039\/C6FO00158K","article-title":"Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates","volume":"7","author":"Sassene","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.ejps.2017.08.003_bb0170","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2013.05.011","article-title":"Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid","volume":"83","author":"Takacs-Novak","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.08.003_bb0175","series-title":"Progress Report on the Paediatric Regulation (EC) N1901\/2006. Com (2013)","volume":"443","author":"The European Commision. Better Medicines for Children From Concept to Reality","year":"2013"},{"key":"10.1016\/j.ejps.2017.08.003_bb0180","series-title":"Guidance for Industry. How to Comply With the Pediatric Research Equity Act. Draft Guidance","author":"U.S.Department of Health and Human Services Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.ejps.2017.08.003_bb0185","author":"U.S.Department of Health and Human Services Food and Drug Administration"},{"issue":"9","key":"10.1016\/j.ejps.2017.08.003_bb0190","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2017.08.003_bb0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/pharmaceutics2040364","article-title":"Drug development for pediatric populations: regulatory aspects","volume":"2","author":"Zisowsky","year":"2010","journal-title":"Pharmaceutics."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:06:52Z","timestamp":1659312412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717304475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"alternative-id":["S0928098717304475"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.08.003","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}